Merrimack Pharmaceuticals (NASDAQ:MACK) Stock Rating Upgraded by StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Merrimack Pharmaceuticals (NASDAQ:MACK) Rating Lowered to Sell at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com lowered shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) from a hold rating to a sell rating in a report issued on Tuesday. Merrimack Pharmaceuticals Stock Down 0.4 % MACK stock opened at $13.25 on Tuesday. The business has a fifty day moving average of $13.10 and a two-hundred day moving average of $12.52. […]
Merrimack Pharmaceuticals (NASDAQ:MACK) Downgraded by StockNews.com to Sell etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.